Which one is a better predictor of prognosis in COVID-19: analytical biomarkers or PaO2/FiO2? M. Rubio-Rivas; J.M. Mora-Luján; A. Montero Sáez; M.D. Martín-Escalante; V. Giner Galvañ; G. Maestro de la Calle; M.L. Taboada Martínez; A. Muiño Míguez; C. Lumbreras-Bermejo; J.-M. Antón-Santos;

Clinical characteristics and risk factors for mortality upon admission in patients with heart failure hospitalized due to COVID-19 in Spain A. Salinas-Botrán; J. Sanz-Cánovas; J. Pérez-Somarriba; L.M. Pérez-Belmonte; L. Cobos-Palacios; M. Rubio-Rivas; S. de-Cossío-Tejido; J.M. Ramos-Rincón; M. Méndez-Bailón; R. Gómez-Huelgas;

Patients with COPD hospitalized due to COVID-19 in Spain: a comparison between the first and second wave M. Gómez-Antúnez; A. Muiño-Míguez; M. Bacete-Cebrián; M. Rubio-Rivas; J.M. Lebrón Ramos; S. de Cossío Tejido; J.J. Peris-García; J.F. López-Caleya; J.M. Casas-Rojo; J. Millán Núñez-Cortés;